GlassScriptPhysician profile
Martha Cohen
NPI 1427306893
$10,137.70
in general payments reported to CMS, 2019-2025
43 companies · $1,202 in 2025
The $1,202 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $3,296 · 2021: $744 · 2022: $1,868 · 2023: $1,435 · 2024: $1,257 · 2025: $1,202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,894.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,028.98 | 2020 | |
| Abbvie INC. | $1,280.83 | 2019-2024 | Lo Loestrin Fe, Orilissa, Liletta |
| Sumitomo Pharma America, INC. | $1,071.70 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $454.36 | 2022-2025 | |
| Exeltis, USA INC. | $400.54 | 2020-2025 | Slynd |
| Shield Therapeutics INC | $399.60 | 2022-2025 | Accrufer |
| Organon LLC | $313.22 | 2021-2025 | Nexplanon, Nuvaring |
| Myovant Sciences INC. | $252.48 | 2021-2022 | |
| Therapeuticsmd, INC. | $219.81 | 2020-2022 | |
| Sage Therapeutics, LLC | $216.80 | 2024-2025 | Zurzuvae |
| Medtronic USA, INC. | $211.11 | 2019 | |
| Astellas Pharma US INC | $209.01 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $192.93 | 2020-2025 | Thinprep 2000 Processor, Aptima, Myosure Tissue Removal Device |
| Channel Medsystems, INC. | $190.84 | 2022-2025 | |
| Mylan Pharmaceuticals INC. | $181.63 | 2021-2022 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $178.60 | 2020-2025 | |
| Optumhealth Care Solutions, LLC | $136.98 | 2023-2025 | Vivify Health Care Team Portal 001, Eitan Medical, Vivify Health Care Team Portal |
| Aspira Women'S Health INC | $134.46 | 2022 | |
| Millicent US INC | $129.59 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Pfizer INC. | $120.86 | 2021-2023 | |
| Agile Therapeutics, INC. | $102.47 | 2021-2024 | Twirla |
| Exact Sciences Corporation | $83.37 | 2023 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $68.14 | 2021-2022 | |
| Scynexis, INC. | $62.74 | 2022 | |
| Dexcom, INC. | $56.68 | 2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $49.90 | 2025 | Wegovy |
| Innovation Technologies INC | $45.26 | 2022 | |
| Merck Sharp & Dohme LLC | $38.97 | 2019-2020 | |
| Ethicon US, LLC | $35.65 | 2019-2024 | Stratafix, Ethicon, Enseal |
| Avion Pharmaceuticals | $32.18 | 2022 | |
| Davol INC. | $30.46 | 2020 | |
| Duchesnay USA Incorporated | $29.73 | 2019 | |
| Trevena, INC. | $23.67 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $22.43 | 2023 | Vivjoa |
| Octapharma USA, INC. | $17.74 | 2025 | Fibryga |
| Meditrina | $17.63 | 2022 | |
| Minerva Surgical, INC | $17.31 | 2025 | |
| Axonics, INC. | $14.98 | 2022 | |
| Boston Scientific Corporation | $13.79 | 2024 | |
| Gynesonics, INC. | $13.74 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbott Laboratories | $12.91 | 2020 | |
| Avanos Medical | $12.18 | 2022 | |
| Lupin INC. | $11.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martha Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.